Gene editing at Meeting on the Mesa 2026
30 organizations at Meeting on the Mesa 2026 present work in gene editing: 21 therapy developers, 8 suppliers and service providers and 1 academic or public organization. Between them they bring 14 presentations to the program. Most represented: Arbor Biotechnologies (1 on the program), ElevateBio (1 on the program). 16 of them have their own page in this guide.
Format
Top represented
Showing 1–19 of 30 organizations
| Organization | Meeting on the Mesa 2026 Attendance |
|---|---|
Arbor Biotechnologies Cambridge, MA | ◇Silver Sponsor |
Develops gene-editing therapeutics for genetic diseases, including liver and central nervous system conditions and rare disorders. | Spotlight Mon, Oct 5 10:45am Innovation Spotlight company presentation Panel Wed, Oct 7 4:15pm |
ElevateBio Waltham, MA | ◆Diamond Sponsor |
Provides gene-editing technologies, discovery services, and cGMP development and manufacturing for advanced therapy companies from early research through commercialization. | Spotlight Mon, Oct 5 11:45am Innovation Spotlight company presentation Panel Wed, Oct 7 5:00pm |
Applied StemCell Milpitas, CA | ◇Silver Sponsor ◇Partnering Sponsor |
Provides CRISPR genome-editing reagents, engineered cell lines, and custom gene-editing services for research and cell therapy development. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Beam Therapeutics Cambridge, MA | ◇Silver Sponsor |
Develops base-editing medicines that precisely modify genes to treat serious diseases. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
BlueRock Therapeutics Cambridge, MA | ◇Silver Sponsor |
Develops engineered cell therapies using pluripotent stem cells and genome editing for neurological, cardiac, and immune diseases. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Editas Medicine Cambridge, MA | ◇Silver Sponsor |
Develops CRISPR-based gene-editing medicines for genetic diseases. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Ascidian Therapeutics Boston, MA | |
Develops RNA exon-editing therapies that restore full-length proteins for retinal, neurological, neuromuscular, renal, and genetically defined diseases. | Spotlight Mon, Oct 5 4:30pm Innovation Spotlight company presentation |
Metagenomi Therapeutics Emeryville, CA | |
Develops genome-editing technologies and therapeutic programs for genetic diseases, including engineered editing systems designed for precision and delivery. | Spotlight Mon, Oct 5 11:45am Innovation Spotlight company presentation |
Precision BioSciences Durham, NC | |
Develops in vivo gene-editing therapies using its ARCUS platform for infectious and rare diseases. | Spotlight Mon, Oct 5 11:30am Innovation Spotlight company presentation |
RheumaGen Aurora, CO | |
Develops HLA gene-editing therapies intended to treat rheumatoid arthritis, multiple sclerosis, and other autoimmune diseases. | Spotlight Tue, Oct 6 9:00am Innovation Spotlight company presentation |
Scribe Therapeutics Alameda, CA | |
Develops CRISPR-based in vivo genetic medicines, including liver-targeted therapies designed to epigenetically silence disease-related genes. | Spotlight Mon, Oct 5 5:15pm Innovation Spotlight company presentation |
Develops Dualase genome-editing therapies delivered by AAV or RNA, initially targeting DNA repeat expansion disorders including inherited ALS. | Spotlight Tue, Oct 6 4:45pm Innovation Spotlight company presentation |
Tessera Therapeutics Cambridge, MA | |
Develops Gene Writing genome-engineering therapies designed to insert therapeutic genetic information into cells and treat disease at its source. | Spotlight Tue, Oct 6 4:00pm Innovation Spotlight company presentation |
Intellia Therapeutics Cambridge, MA | |
Develops CRISPR-based gene-editing therapies for serious diseases, including in vivo and engineered-cell treatment programs. | Panel Wed, Oct 7 9:30am |
Pluristyx Seattle, WA | |
Provides research and clinical-grade iPSC products, gene-editing technologies, cell differentiation, and development services for cell therapy developers. | Panel Wed, Oct 7 5:00pm |
Prime Medicine Cambridge, MA | |
Develops gene therapies using Prime Editing to precisely correct disease-causing mutations. | Panel Wed, Oct 7 9:30am |
Cartherics Melbourne, Australia | |
Develops off-the-shelf immune cell therapies using gene-edited cells for ovarian cancer, endometriosis and other diseases. | Attending On the meeting’s published attendee list |
GenScript Nanjing, China | |
Provides gene synthesis, genome-editing, plasmid, viral-vector, cell-therapy and biologics development and manufacturing services, plus research reagents. | Attending On the meeting’s published attendee list |
Helex Cambridge, MA | |
Develops gene-editing medicines using lipid nanoparticles to treat genetic kidney diseases. | Attending On the meeting’s published attendee list |
Instantly find 20 buyers in gene editing
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse Meeting on the Mesa 2026 by
Organization type
Focus area
Everyone
Not affiliated with or endorsed by the Alliance for Regenerative Medicine or the Cell & Gene Meeting on the Mesa. Submit a correction